Giuseppe Ciaramella

This study uses adenine base editing to target HBV DNA and suppress HBsAg production and HDV release in vitro and in vivo.

The paper develops next-generation cytosine base editors with reduced off-target DNA and RNA deamination and improved on-target activity.

This paper evolves adenine base editors (ABE8s) to improve editing efficiency and demonstrates their therapeutic application in human cells.